Literature DB >> 3929607

Alloimmunization in twin pregnancies.

J M Bowman.   

Abstract

Of 118 twins born of 59 alloimmunized mothers from 1944 to 1984, 65 were Rh-positive and six died. One twin in one of the 59 sets and four sets of twins referred from elsewhere underwent intrauterine fetal transfusion. The Manitoba twin and two pairs of the four referred sets survived. Fetal transfusions were begun at 22 2/7 and 24 1/7 weeks' gestation in one surviving set and 23 3/7 weeks in both twins of the other surviving set. Three twins of the four who died were hydropic at referral. There would have been a 62.5% chance of survival if they had been referred at 23 weeks' gestation. ABO incompatibility in one twin of three sets had no effect on the amelioration of severity of Rh disease. In three sets, gross hemoglobin disparities were due to twin-to-twin transfusion. Differences in degree of severity of disease in the other four dichorionic sets may have been due to differences in sex, Rh constitution, amount of fetal erythropoiesis, and fetal hepatocellular function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929607     DOI: 10.1016/0002-9378(85)90581-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Retrospective analysis of 55 twin neonates with haemolytic disease of the newborn.

Authors:  Hu Zhao; Bijuan Li; Ning Li; Yamei Shen; Kailiang Liu; Xiangwu Shu; Cheng Mei; Lanlan Tang
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

2.  Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy.

Authors:  K Elasoud; G McClure; H L Halliday; J C Dornan
Journal:  Ulster Med J       Date:  1997-05

3.  Fetal death: an extreme manifestation of maternal anti-fetal rejection.

Authors:  Kia Lannaman; Roberto Romero; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Steven J Korzeniewski; Eli Maymon; Nardhy Gomez-Lopez; Bogdan Panaitescu; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Chong Jai Kim; Offer Erez
Journal:  J Perinat Med       Date:  2017-10-26       Impact factor: 1.901

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.